Merit Medical Systems, Inc. $MMSI Shares Bought by Fort Washington Investment Advisors Inc. OH

Fort Washington Investment Advisors Inc. OH grew its position in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 31.1% in the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 420,873 shares of the medical instruments supplier’s stock after buying an additional 99,850 shares during the quarter. Fort Washington Investment Advisors Inc. OH’s holdings in Merit Medical Systems were worth $29,011,000 as of its most recent filing with the SEC.

Several other hedge funds also recently made changes to their positions in MMSI. Los Angeles Capital Management LLC purchased a new stake in shares of Merit Medical Systems in the fourth quarter valued at about $25,000. Maseco LLP acquired a new position in shares of Merit Medical Systems during the fourth quarter worth about $26,000. Torren Management LLC purchased a new position in Merit Medical Systems during the fourth quarter worth about $38,000. Covestor Ltd raised its holdings in Merit Medical Systems by 252.6% during the fourth quarter. Covestor Ltd now owns 469 shares of the medical instruments supplier’s stock worth $41,000 after purchasing an additional 336 shares in the last quarter. Finally, Danske Bank A S acquired a new stake in Merit Medical Systems in the third quarter valued at about $42,000. Institutional investors and hedge funds own 99.66% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have weighed in on MMSI. Wells Fargo & Company lowered their price objective on Merit Medical Systems from $78.00 to $74.00 and set an “equal weight” rating on the stock in a report on Friday, May 1st. Piper Sandler cut their target price on Merit Medical Systems from $106.00 to $96.00 and set an “overweight” rating for the company in a research note on Friday, April 17th. Barrington Research reduced their price target on Merit Medical Systems from $109.00 to $107.00 and set an “outperform” rating for the company in a report on Monday, April 20th. Needham & Company LLC decreased their price target on Merit Medical Systems from $101.00 to $90.00 and set a “buy” rating on the stock in a research note on Friday, May 1st. Finally, Citigroup reaffirmed an “outperform” rating on shares of Merit Medical Systems in a report on Monday, April 20th. Eight investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $92.80.

Merit Medical Systems Price Performance

MMSI stock opened at $71.73 on Monday. The company has a market cap of $4.28 billion, a P/E ratio of 31.05, a P/E/G ratio of 2.23 and a beta of 0.54. Merit Medical Systems, Inc. has a 52 week low of $59.74 and a 52 week high of $96.74. The company’s 50-day moving average price is $65.38 and its 200 day moving average price is $74.11. The company has a current ratio of 5.08, a quick ratio of 3.46 and a debt-to-equity ratio of 0.45.

Merit Medical Systems (NASDAQ:MMSI) last issued its earnings results on Thursday, April 30th. The medical instruments supplier reported $0.94 earnings per share for the quarter, topping the consensus estimate of $0.84 by $0.10. Merit Medical Systems had a net margin of 9.03% and a return on equity of 13.54%. The company had revenue of $381.88 million for the quarter, compared to analyst estimates of $377.59 million. During the same period in the prior year, the business posted $0.86 earnings per share. The firm’s revenue for the quarter was up 7.4% compared to the same quarter last year. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. On average, research analysts expect that Merit Medical Systems, Inc. will post 3.62 earnings per share for the current fiscal year.

Insider Activity at Merit Medical Systems

In related news, Director Lynne N. Ward sold 5,000 shares of Merit Medical Systems stock in a transaction on Thursday, May 7th. The stock was sold at an average price of $62.61, for a total transaction of $313,050.00. Following the completion of the transaction, the director directly owned 7,809 shares of the company’s stock, valued at approximately $488,921.49. The trade was a 39.04% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, insider Brian G. Lloyd bought 2,000 shares of the firm’s stock in a transaction on Thursday, May 7th. The shares were purchased at an average price of $62.62 per share, for a total transaction of $125,240.00. Following the completion of the transaction, the insider owned 2,000 shares of the company’s stock, valued at $125,240. This represents a ∞ increase in their position. The SEC filing for this purchase provides additional information. 0.70% of the stock is owned by insiders.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.